Global Tumor Tracking Systems Market is expected to reach $XX Mn in 2026 from $XX Mn in 2019, at a CAGR of XX% during forecast period.
Global Tumor Tracking Systems Market Overview:
Tumor tracking systems are used to track the tumor in patient body. It is important for radiation therapy to deliver sufficient radiation dose without damaging the surrounding healthy tissue. Localization of tumor becomes difficult due to patient’s position shift, change of tumor area during series of treatment, and tumor movement due to respiration. Tumor Tracking Systems make imaging and radiotherapy more precise and safer for patients.
Global Tumor Tracking Systems Market Dynamics:
Rising prevalence of tumor cancer and technological advancements drive the market growth.
Cancer is one of the leading causes of death globally. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. Use of technologically advanced devices like Calypso, which provides real-time tumor tracking with benefits such as no requirement of ionization radiation during localization of tumor. These devices help surgeons to perform treatment with minimal complications. Increasing research and development activities to find the cure for various cancer types and locate the tumor precisely further expected to drive the growth of the tumor tracking systems market.
The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing RD activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.
Global Tumor Tracking Systems Market Segment Analysis:
The global tumor tracking systems market is segmented on the basis of device type, application and end-user.
Based on Application, Prostate Cancer segment dominates the market as it is the second-highest form of cancer affecting men worldwide. As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. Due to such a high prevalence of prostate cancer, demand for tumor tracking is expected to rise during the forecast years.
Global Tumor Tracking Systems Market by Application
To Know About The Research Methodology :- Request Free Sample Report
Global Tumor Tracking Systems Market Regional Insights:
Global Tumor Tracking Systems Market by Regional
North America dominates the global Tumor Tracking Systems Market.
The prevalence of prostate and breast cancer in the region is the major driving factor for the market growth. Increasing investments from the government in the use of biomarkers in drug discovery, detection of specific tumors and genetic studies for the identification of cancer propels the market growth in the region. Also, high awareness, availability of reimbursement policies, and high cost of the products in the U.S. propel the tumor tracking systems market in North America.
The report also helps in understanding Global Tumor Tracking Systems Market dynamics, structure by analyzing the market segments and projects the Global Tumor Tracking Systems Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Tumor Tracking Systems Market make the report investor’s guide.
Global Tumor Tracking Systems Market scope: Inquire before buying
Global Tumor Tracking Systems Market by Scope
Global Tumor Tracking Systems Market, by Region:
• North America
• South America
Global Tumor Tracking Systems Market Key Players:
• Varian Medical Systems, Inc.
• Accuray Incorporated
• Elekta AB
• Thermo Fisher Scientific
• Miltenyi Biotec
• Cell Biolabs, Inc.
• STEMCELL Technologies Inc.
• Menarini Silicon Biosystems, Inc.
• Koninklijke Philips N.V.
• CureMD Healthcare
• RaySearch Laboratories AB
• MICA Information Systems, Inc.